Search Within

Matthew David Hellmann

  1. "2014"
Formats
  1. Meeting Abstract (8)
  2. Journal Article (6)
Groups
  1. Department of Medicine (14)
  2. Solid Tumor Oncology Division (14)
  3. Thoracic Oncology (14)
  4. Department of Pathology and Laboratory Medicine (10)
  5. GSK Faculty (6)
  6. Human Oncology and Pathogenesis Program (5)

More Groups

People
  1. Mark Kris (9)
  2. Camelia Sima (7)
  3. Helena Yu (5)
  4. Marc Ladanyi (5)
  5. Maria Arcila (5)
  6. Naiyer Rizvi (4)

More People

Years
  1. 2014 (14)
Publications
  1. Journal of Clinical Oncology (6)
  2. Journal of Thoracic Oncology (3)
  3. Annals of Oncology (2)
  4. American Society of Clinical Oncology Educational Book (1)
  5. Journal for ImmunoTherapy of Cancer (1)
  6. Lancet Oncology (1)
Publishers
  1. American Society of Clinical Oncology (7)
  2. Elsevier Inc. (3)
  3. Oxford University Press (2)
  4. Biomed Central Ltd (1)
  5. Elsevier Science, Inc. (1)

Results (14)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Opportunistic infections in patients treated with immunotherapy for cancer
    Journal Article

    Kyi, C.; Hellmann, M. D.; Wolchok, J. D.; Chapman, P. B.; Postow, M. A.
    Journal for ImmunoTherapy of Cancer (2014)

    Fulltext@MSK | Save
  • Chemotherapy for lung cancers: Here to stay
    Journal Article

    Kris, M. G.; Hellmann, M. D.; Chaft, J. E.
    American Society of Clinical Oncology Educational Book (2014)

    Fulltext@MSK | Save
  • Stage at diagnosis as a prognostic marker for patients with KRAS-mutant metastatic lung adenocarcinomas
    Meeting Abstract

    Yu, H. A.; Hellmann, M. D.; Sima, C. S.; Busby, N.; Rodriguez, K.; Riely, G. J.; Kris, M. G.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • NEOSCAN: Phase II trial of neoadjuvant chemotherapy for resectable lung cancers with switch to chemo alternative in (18)F-FDG PET nonresponders
    Meeting Abstract

    Kris, M. G.; Hellmann, M. D.; Naidoo, J.; Dunphy, M.; Sima, C. S.; Downey, R. J.; Travis, W. D.; Azzoli, C. G.; Chaft, J. E.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Prevalence of germline BAP1 mutations in patients with malignant mesothelioma (MM)
    Meeting Abstract

    Hellmann, M. D.; Borsu, L.; Zehir, A.; Cheng, D. T.; Zha, Z.; Siegel, B.; Rohrer, R. W.; Robson, M. E.; Arnold, A. G.; Fleischut, M. H.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Clinicopathologic characteristics and prognostic impact of MET receptor overexpression in patients with stage I-IIIA squamous cell lung carcinomas (SQCLCs)
    Meeting Abstract

    Hellmann, M. D.; Anderson, T. A.; Eng, J.; Sima, C. S.; Kris, M. G.; Moreira, A. L.; Rekhtman, N.; Paik, P. K.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Alterations in two oncogenic drivers: Impact of concurrent PIK3CA or AKT1 mutations in patients with oncogene-driven lung adenocarcinomas
    Meeting Abstract

    Eng, J.; Hellmann, M. D.; Woo, K.; Sima, C. S.; Yu, H. A.; Arcila, M. E.; Ladanyi, M.; Kris, M. G.; Drilon, A. E.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Clinicopathologic features of advanced RET fusion-positive lung cancers and outcomes in comparison to other fusion-positive lung cancers
    Meeting Abstract

    Drilon, A. E.; Hellmann, M. D.; Wang, L.; Cho, E. J.; Ladanyi, M.; Rizvi, N. A.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Clinical and in vivo evidence that EGFR S768I mutant lung adenocarcinomas are sensitive to erlotinib
    Journal Article

    Hellmann, M. D.; Reva, B.; Yu, H.; Rusch, V. W.; Rizvi, N. A.; Kris, M. G.; Arcila, M. E.
    Journal of Thoracic Oncology (2014)

    Fulltext@MSK | Save
  • Smoking history and response to nivolumab in patients with advanced NSCLCS
    Meeting Abstract

    Hellmann, M. D.; Creelan, B. C.; Woo, K.; Sima, C. S.; Iams, W. T.; Antonia, S. J.; Horn, L.; Brahmer, J. R.; Gettinger, S.; Harbison, C.; more...
    Annals of Oncology (2014)

    Fulltext@MSK | Save